Will Biogen win Tecfidera appeal?



















Does not matter because Banner has generic bafiertam which mco , spp will soon consider ab rated regardless of Biogen s desperate attempt switch patient off tecfidera to vumerity. Wait until June updated policies come out and sales tank.
It is over for tecfidera or vumerity. Patients still having gi problems and shitting their pants:)))
 






Look, none of this matters. Especially if adu doesn’t hit.

BIOGEN is teaming with sycophantic no-nothings. Right now feelings are WAY more important than facts within the company. It’s an echo chamber of its own demise. For every qualified team member, we’ve easily got 10-20 (that’s being kind) that are obstructionist filler That’s biogen greatest threat right now.

the call is coming from inside the house.
 






Novartis has taken it too them big time. Biogen the MS company is crumbling. Biogen will have to try to become an Alzheimer’s company now.

With zero approved or likely to be approved Alzheimer’s assets, that is going to be one valuable company!

People focus on the adu drama, but Biogen screwing up their patent and losing exclusivity several years early on Tec was the nail in the coffin.
 






Spot on. We don’t even need to worry about getting killed by our considerable competition. We are killing ourselves internally with the layers and layers and layers of middle management that does nothing except prop up and provide cover for other shitty middle managers.

Look, none of this matters. Especially if adu doesn’t hit.

BIOGEN is teaming with sycophantic no-nothings. Right now feelings are WAY more important than facts within the company. It’s an echo chamber of its own demise. For every qualified team member, we’ve easily got 10-20 (that’s being kind) that are obstructionist filler That’s biogen greatest threat right now.

the call is coming from inside the house.
 












Biogen has been a sinking ship since 2017 when they brought on the Novartis lackies who couldn't run their hand through their hair correctly. Look at who gets promoted and the quality of leadership..... you got your answer right there.
 






Does not matter because Banner has generic bafiertam which mco , spp will soon consider ab rated regardless of Biogen s desperate attempt switch patient off tecfidera to vumerity. Wait until June updated policies come out and sales tank.
It is over for tecfidera or vumerity. Patients still having gi problems and shitting their pants:)))

Well, that didn't happen!
 






Look, none of this matters. Especially if adu doesn’t hit.

BIOGEN is teaming with sycophantic no-nothings. Right now feelings are WAY more important than facts within the company. It’s an echo chamber of its own demise. For every qualified team member, we’ve easily got 10-20 (that’s being kind) that are obstructionist filler That’s biogen greatest threat right now.

the call is coming from inside the house.

Yep.